|
|
|
|
|
|
|
||
J. Exp. Med.,
Volume 188, Number 2, July 20, 1998 277-286
By
From the * Surgery Branch and the Many tumor-associated antigens are nonmutated, poorly immunogenic tissue differentiation
antigens. Their weak immunogenicity may be due to "self"-tolerance. To induce autoreactive T
cells, we studied immune responses to gp100/pmel 17, an antigen naturally expressed by both
normal melanocytes and melanoma cells. Although a recombinant vaccinia virus (rVV) encoding the mouse homologue of gp100 was nonimmunogenic, immunization of normal C57BL/6
mice with the rVV encoding the human gp100 elicited a specific CD8+ T cell response. These
lymphocytes were cross-reactive with mgp100 in vitro and treated established B16 melanoma
upon adoptive transfer. To understand the mechanism of the greater immunogenicity of the human version of gp100, we characterized a 9-amino acid (AA) epitope, restricted by H-2Db,
that was recognized by the T cells. The ability to induce specific T cells with human but not
mouse gp100 resulted from differences within the major histocompatibility complex (MHC)
class I-restricted epitope and not from differences elsewhere in the molecule, as was evidenced
by experiments in which mice were immunized with rVV containing minigenes encoding
these epitopes. Although the human (hgp10025-33) and mouse (mgp10025-33) epitopes were homologous, differences in the three NH2-terminal AAs resulted in a 2-log increase in the ability
of the human peptide to stabilize "empty" Db on RMA-S cells and a 3-log increase in its ability
to trigger interferon Metabolism Branch, National Cancer Institute, National Institutes
of Health, Bethesda, Maryland 20892; the § Department of Surgery, Veterans Administration Medical
Center, University of California San Francisco, San Francisco, California 94121; and the Laboratory
of Viral Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892
release by T cells. Thus, the fortuitous existence of a peptide homologue
with significantly greater avidity for MHC class I resulted in the generation of self-reactive T
cells. High-affinity, altered peptide ligands might be useful in the rational design of recombinant and synthetic vaccines that target tissue differentiation antigens expressed by tumors.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
| TABLE OF CONTENTS |
|
